Showing results (101-110 of 149) with videos related to
Sort By:
Pageof 15
Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 14, 2021
Multicentric non-enhancing lesions in glioblastoma: A retrospective studyAlexandra Benouaich-Amiel, Vadim Khasminsky, Omer Gal, et al.Haematologica|February 10, 2015
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experienceYair Herishanu, Neta Goldschmidt, Osnat Bairey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Chemotherapy delivery issues in central nervous system malignancy: a reality checkLeslie L Muldoon, Carole Soussain, Kristoph Jahnke, et al.Journal of the Neurological Sciences|February 8, 2025
The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based careEfraim Waizman, Elizabeth Dudnik, Inbar Lavie, et al.Journal of Neuro-Oncology|February 12, 2018
Brain metastasis in gastroesophageal adenocarcinoma and HER2 statusDror Limon, Omer Gal, Noa Gordon, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2005
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiformeArnold I Freeman, Zichria Zakay-Rones, John M Gomori, et al.American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.Annals of Hematology|June 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort studyTamar Berger, Tzippy Shochat, Shlomzion Aumann, et al.European Journal of Haematology|June 28, 2018
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trialsErel Joffe, Neta Goldschmidt, Osnat Bairey, et al.Pageof 15